These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 16470173)

  • 1. Clonal persistence and evolution during a decade of recurrent melanoma.
    Wang E; Voiculescu S; Le Poole IC; El-Gamil M; Li X; Sabatino M; Robbins PF; Nickoloff BJ; Marincola FM
    J Invest Dermatol; 2006 Jun; 126(6):1372-7. PubMed ID: 16470173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Conservation of genetic alterations in recurrent melanoma supports the melanoma stem cell hypothesis.
    Sabatino M; Zhao Y; Voiculescu S; Monaco A; Robbins P; Karai L; Nickoloff BJ; Maio M; Selleri S; Marincola FM; Wang E
    Cancer Res; 2008 Jan; 68(1):122-31. PubMed ID: 18172304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Longitudinal study of recurrent metastatic melanoma cell lines underscores the individuality of cancer biology.
    Pos Z; Spivey TL; Liu H; Sommariva M; Chen J; Wunderlich JR; Parisi G; Tomei S; Ayotte BD; Stroncek DF; Malek JA; Robbins PF; Rivoltini L; Maio M; Chouchane L; Wang E; Marincola FM
    J Invest Dermatol; 2014 May; 134(5):1389-1396. PubMed ID: 24270663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple metastases from cutaneous malignant melanoma patients may display heterogeneous genomic and epigenomic patterns.
    Harbst K; Staaf J; Måsbäck A; Olsson H; Ingvar C; Vallon-Christersson J; Ringnér M; Borg A; Jönsson G
    Melanoma Res; 2010 Oct; 20(5):381-91. PubMed ID: 20848731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic Evolution of Clonal Composition and Neoantigen Landscape in Recurrent Metastatic Melanoma with a Rare Combination of Driver Mutations.
    Davidson G; Coassolo S; Kieny A; Ennen M; Pencreach E; Malouf GG; Lipsker D; Davidson I
    J Invest Dermatol; 2019 Aug; 139(8):1769-1778.e2. PubMed ID: 30776432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of KIT expression and gene mutation in human acral melanoma: with a comparison between primary tumors and corresponding metastases/recurrences.
    Dai B; Cai X; Kong YY; Yang F; Shen XX; Wang LW; Kong JC
    Hum Pathol; 2013 Aug; 44(8):1472-8. PubMed ID: 23528861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetically heterogeneous and clonally unrelated metastases may arise in patients with cutaneous melanoma.
    Katona TM; Jones TD; Wang M; Eble JN; Billings SD; Cheng L
    Am J Surg Pathol; 2007 Jul; 31(7):1029-37. PubMed ID: 17592269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of heterozygosity in the MXI1 gene is a frequent occurrence in melanoma.
    Ariyanayagam-Baksh SM; Baksh FK; Swalsky PA; Finkelstein SD
    Mod Pathol; 2003 Oct; 16(10):992-5. PubMed ID: 14559981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Nuclear beta-catenin localization is not sufficient for canonical Wnt signaling activation in human meianoma cell lines].
    Kulikova KV; Posviatenko AV; Gnuchev NV; Georgiev GP; Kibardin AV; Larin SS
    Mol Biol (Mosk); 2011; 45(5):884-91. PubMed ID: 22393786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of genetic profiles between primary melanomas and their metastases reveals genetic alterations and clonal evolution during progression.
    Morita R; Fujimoto A; Hatta N; Takehara K; Takata M
    J Invest Dermatol; 1998 Dec; 111(6):919-24. PubMed ID: 9856796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of membranous expression of beta-catenin is associated with tumor progression in cutaneous melanoma and rarely caused by exon 3 mutations.
    Demunter A; Libbrecht L; Degreef H; De Wolf-Peeters C; van den Oord JJ
    Mod Pathol; 2002 Apr; 15(4):454-61. PubMed ID: 11950921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
    Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
    Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melanoma, a tumor based on a mutant stem cell?
    Grichnik JM; Burch JA; Schulteis RD; Shan S; Liu J; Darrow TL; Vervaert CE; Seigler HF
    J Invest Dermatol; 2006 Jan; 126(1):142-53. PubMed ID: 16417230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metastatic lesions with and without interleukin-18-dependent genes in advanced-stage melanoma patients.
    Crende O; Sabatino M; Valcárcel M; Carrascal T; Riestra P; López-Guerrero JA; Nagore E; Mandruzzato S; Wang E; Marincola FM; Vidal-Vanaclocha F
    Am J Pathol; 2013 Jul; 183(1):69-82. PubMed ID: 23707237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Establishment of a novel Chinese metastatic melanoma cell line showing the new cytogenetic and biological properties.
    Yi X; Zhu G; Li Y; Liu Y; Luan Q; Dai W; Wang L; Liao W; Gao T; Li C
    Cell Biol Int; 2015 Apr; 39(4):508-14. PubMed ID: 25639772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that intravenously derived murine pulmonary melanoma metastases can originate from the expansion of a single tumor cell.
    Fidler IJ; Talmadge JE
    Cancer Res; 1986 Oct; 46(10):5167-71. PubMed ID: 3756870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic analysis of melanoma evolution following a 30-year disease-free interval.
    Miller JJ; Lofgren KA; Hughes SR; Cash SE; Kenny PA
    J Cutan Pathol; 2017 Sep; 44(9):805-808. PubMed ID: 28628281
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct visualization of the clonal progression of primary cutaneous melanoma: application of tissue microdissection and comparative genomic hybridization.
    Wiltshire RN; Duray P; Bittner ML; Visakorpi T; Meltzer PS; Tuthill RJ; Liotta LA; Trent JM
    Cancer Res; 1995 Sep; 55(18):3954-7. PubMed ID: 7664261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Primary dermal melanoma: a unique subtype of melanoma to be distinguished from cutaneous metastatic melanoma: a clinical, histologic, and gene expression-profiling study.
    Sidiropoulos M; Obregon R; Cooper C; Sholl LM; Guitart J; Gerami P
    J Am Acad Dermatol; 2014 Dec; 71(6):1083-92. PubMed ID: 25262174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical treatment options for stage IV melanoma.
    Wei IH; Healy MA; Wong SL
    Surg Clin North Am; 2014 Oct; 94(5):1075-89, ix. PubMed ID: 25245969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.